MyoTherix Overview

  • Founded
  • 2013
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $8.43M
Latest Deal Amount
  • Investors
  • 1

MyoTherix General Information


Developer of innovative therapeutics intended to be used for the treatment of muscle disorders. The company utilizes an innovative and novel approach to target both cardiac and skeletal muscle weakness, enabling patients to avail disease-modifying drugs and therapies and stay fit and healthy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • 1900 Powell Street
  • 6th Floor
  • Emeryville, CA 94608
  • United States
+1 (857) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MyoTherix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 27-Feb-2017 $8.43M 00.00 Completed Startup
1. Early Stage VC (Series A) 08-Jul-2015 000 000 000 Completed Startup
To view MyoTherix’s complete valuation and funding history, request access »

MyoTherix Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00 00 00 00 00.00
To view MyoTherix’s complete cap table history, request access »

MyoTherix Executive Team (5)

Name Title Board Seat Contact Info
Michael Kelly Ph.D Co-Founder, Chief Executive Officer, President & Board Member
John Kincaid Co-Founder & Board Member
Giles Campion MD Chief Medical Officer
Mark De Souza Ph.D Co-Founder, Chief Operating Officer & Chairman
To view MyoTherix’s complete executive team members history, request access »

MyoTherix Board Members (5)

Name Representing Role Since
Babar Ghias Self Board Member 000 0000
John Kincaid MyoTherix Co-Founder & Board Member 000 0000
Mark De Souza Ph.D Self Co-Founder, Chief Operating Officer & Chairman 000 0000
Michael Kelly Ph.D MyoTherix Co-Founder, Chief Executive Officer, President & Board Member 000 0000
To view MyoTherix’s complete board members history, request access »

MyoTherix Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CureDuchenne Ventures Corporate Venture Capital Minority 000 0000 000000 0
To view MyoTherix’s complete investors history, request access »